Medexus is a leading orphan drug and rare disease pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative treatment solutions
Medexus is a leading orphan drug and rare disease pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative treatment solutions. The company focuses on hematology, hematology-oncology, rheumatology, and allergy.